BNP Paribas Financial Markets’s Galectin Therapeutics GALT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.29K | Hold |
1,559
| – | – | ﹤0.01% | 4190 |
|
|
2025
Q1 | $1.9K | Sell |
1,559
-4,041
| -72% | -$4.93K | ﹤0.01% | 4153 |
|
|
2024
Q4 | $7.22K | Buy |
5,600
+145
| +3% | +$187 | ﹤0.01% | 4039 |
|
|
2024
Q3 | $15K | Buy |
5,455
+3,990
| +272% | +$11K | ﹤0.01% | 3045 |
|
|
2024
Q2 | $3.31K | Buy |
+1,465
| New | +$3.31K | ﹤0.01% | 3109 |
|
|
2022
Q4 | – | Sell |
-13
| Closed | -$21 | – | 3562 |
|
|
2022
Q3 | $21 | Hold |
13
| – | – | ﹤0.01% | 3976 |
|
|
2022
Q2 | $17 | Hold |
13
| – | – | ﹤0.01% | 3416 |
|
|
2022
Q1 | $21 | Hold |
13
| – | – | ﹤0.01% | 3547 |
|
|
2021
Q4 | $27 | Sell |
13
-629
| -98% | -$1.31K | ﹤0.01% | 3527 |
|
|
2021
Q3 | $2.49K | Hold |
642
| – | – | ﹤0.01% | 3168 |
|
|
2021
Q2 | $2.05K | Sell |
642
-4,643
| -88% | -$14.9K | ﹤0.01% | 3281 |
|
|
2021
Q1 | $11.5K | Sell |
5,285
-1,660
| -24% | -$3.6K | ﹤0.01% | 3247 |
|
|
2020
Q4 | $15.6K | Sell |
6,945
-1,484
| -18% | -$3.32K | ﹤0.01% | 3225 |
|
|
2020
Q3 | $22.5K | Buy |
8,429
+7,171
| +570% | +$19.1K | ﹤0.01% | 3166 |
|
|
2020
Q2 | $3.85K | Sell |
1,258
-11,202
| -90% | -$34.3K | ﹤0.01% | 3460 |
|
|
2020
Q1 | $24.4K | Buy |
12,460
+6,656
| +115% | +$13K | ﹤0.01% | 3237 |
|
|
2019
Q4 | $16.6K | Buy |
5,804
+1,705
| +42% | +$4.88K | ﹤0.01% | 3377 |
|
|
2019
Q3 | $15K | Buy |
4,099
+4,016
| +4,839% | +$14.7K | ﹤0.01% | 3418 |
|
|
2019
Q2 | $344 | Buy |
+83
| New | +$344 | ﹤0.01% | 3804 |
|
|
2015
Q2 | – | Sell |
-384
| Closed | -$1.29K | – | 3569 |
|
|
2015
Q1 | $1.29K | Buy |
+384
| New | +$1.29K | ﹤0.01% | 3536 |
|
|
2014
Q4 | – | Sell |
-897
| Closed | -$4.51K | – | 2281 |
|
|
2014
Q3 | $4.51K | Buy |
+897
| New | +$4.51K | ﹤0.01% | 3307 |
|